1. Home
  2. EVAX vs IBIO Comparison

EVAX vs IBIO Comparison

Compare EVAX & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • IBIO
  • Stock Information
  • Founded
  • EVAX 2008
  • IBIO 2008
  • Country
  • EVAX Denmark
  • IBIO United States
  • Employees
  • EVAX N/A
  • IBIO N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • IBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVAX Health Care
  • IBIO Health Care
  • Exchange
  • EVAX Nasdaq
  • IBIO Nasdaq
  • Market Cap
  • EVAX 10.8M
  • IBIO 9.3M
  • IPO Year
  • EVAX 2021
  • IBIO N/A
  • Fundamental
  • Price
  • EVAX $3.13
  • IBIO $0.98
  • Analyst Decision
  • EVAX Strong Buy
  • IBIO Strong Buy
  • Analyst Count
  • EVAX 2
  • IBIO 3
  • Target Price
  • EVAX $10.00
  • IBIO $4.87
  • AVG Volume (30 Days)
  • EVAX 134.8K
  • IBIO 452.8K
  • Earning Date
  • EVAX 05-27-2025
  • IBIO 05-02-2025
  • Dividend Yield
  • EVAX N/A
  • IBIO N/A
  • EPS Growth
  • EVAX N/A
  • IBIO N/A
  • EPS
  • EVAX N/A
  • IBIO N/A
  • Revenue
  • EVAX $3,293,000.00
  • IBIO $375,000.00
  • Revenue This Year
  • EVAX N/A
  • IBIO $36.00
  • Revenue Next Year
  • EVAX N/A
  • IBIO N/A
  • P/E Ratio
  • EVAX N/A
  • IBIO N/A
  • Revenue Growth
  • EVAX 2555.64
  • IBIO 650.00
  • 52 Week Low
  • EVAX $1.20
  • IBIO $0.64
  • 52 Week High
  • EVAX $19.95
  • IBIO $6.89
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 75.25
  • IBIO 48.45
  • Support Level
  • EVAX $2.58
  • IBIO $0.75
  • Resistance Level
  • EVAX $2.84
  • IBIO $1.03
  • Average True Range (ATR)
  • EVAX 0.25
  • IBIO 0.08
  • MACD
  • EVAX 0.10
  • IBIO 0.08
  • Stochastic Oscillator
  • EVAX 96.79
  • IBIO 75.74

About EVAX Evaxion Biotech

Evaxion AS is in the field of oncology. It used the AI-Immunology platform.

About IBIO iBio Inc.

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

Share on Social Networks: